MERCK & CO. INC. (6MK.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:6MK • US58933Y1055

103.2 EUR
+1.8 (+1.78%)
Last: Feb 5, 2026, 07:00 PM
Fundamental Rating

6

Taking everything into account, 6MK scores 6 out of 10 in our fundamental rating. 6MK was compared to 55 industry peers in the Pharmaceuticals industry. 6MK scores excellent on profitability, but there are some minor concerns on its financial health. 6MK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • 6MK had positive earnings in the past year.
  • In the past year 6MK had a positive cash flow from operations.
  • Each year in the past 5 years 6MK has been profitable.
  • In the past 5 years 6MK always reported a positive cash flow from operatings.
6MK.DE Yearly Net Income VS EBIT VS OCF VS FCF6MK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

  • 6MK's Return On Assets of 14.69% is amongst the best of the industry. 6MK outperforms 83.64% of its industry peers.
  • 6MK has a better Return On Equity (36.71%) than 87.27% of its industry peers.
  • 6MK has a Return On Invested Capital (12.83%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 6MK is in line with the industry average of 14.23%.
Industry RankSector Rank
ROA 14.69%
ROE 36.71%
ROIC 12.83%
ROA(3y)9.42%
ROA(5y)9.66%
ROE(3y)23.17%
ROE(5y)26.32%
ROIC(3y)13.67%
ROIC(5y)12.02%
6MK.DE Yearly ROA, ROE, ROIC6MK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • 6MK has a Profit Margin of 29.63%. This is amongst the best in the industry. 6MK outperforms 90.91% of its industry peers.
  • In the last couple of years the Profit Margin of 6MK has remained more or less at the same level.
  • 6MK has a better Operating Margin (38.08%) than 87.27% of its industry peers.
  • 6MK's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 78.72%, 6MK is in the better half of the industry, outperforming 76.36% of the companies in the same industry.
  • 6MK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.08%
PM (TTM) 29.63%
GM 78.72%
OM growth 3Y5.75%
OM growth 5Y7.99%
PM growth 3Y-0.15%
PM growth 5Y1.18%
GM growth 3Y1.92%
GM growth 5Y1.45%
6MK.DE Yearly Profit, Operating, Gross Margins6MK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • 6MK has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, 6MK has about the same amount of shares outstanding.
  • Compared to 5 years ago, 6MK has less shares outstanding
  • Compared to 1 year ago, 6MK has an improved debt to assets ratio.
6MK.DE Yearly Shares Outstanding6MK.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
6MK.DE Yearly Total Debt VS Total Assets6MK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • 6MK has an Altman-Z score of 4.37. This indicates that 6MK is financially healthy and has little risk of bankruptcy at the moment.
  • 6MK has a Altman-Z score of 4.37. This is comparable to the rest of the industry: 6MK outperforms 56.36% of its industry peers.
  • 6MK has a debt to FCF ratio of 3.17. This is a good value and a sign of high solvency as 6MK would need 3.17 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 3.17, 6MK is doing good in the industry, outperforming 65.45% of the companies in the same industry.
  • A Debt/Equity ratio of 0.77 indicates that 6MK is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.77, 6MK perfoms like the industry average, outperforming 47.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 3.17
Altman-Z 4.37
ROIC/WACC1.44
WACC8.93%
6MK.DE Yearly LT Debt VS Equity VS FCF6MK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.66 indicates that 6MK should not have too much problems paying its short term obligations.
  • The Current ratio of 6MK (1.66) is better than 65.45% of its industry peers.
  • A Quick Ratio of 1.44 indicates that 6MK should not have too much problems paying its short term obligations.
  • 6MK's Quick ratio of 1.44 is fine compared to the rest of the industry. 6MK outperforms 70.91% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.44
6MK.DE Yearly Current Assets VS Current Liabilites6MK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 48.07% over the past year.
  • Measured over the past years, 6MK shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.04% on average per year.
  • The Revenue has been growing slightly by 1.68% in the past year.
  • 6MK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.40% yearly.
EPS 1Y (TTM)48.07%
EPS 3Y6.87%
EPS 5Y8.04%
EPS Q2Q%70.7%
Revenue 1Y (TTM)1.68%
Revenue growth 3Y9.63%
Revenue growth 5Y10.4%
Sales Q2Q%3.72%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.65% on average over the next years.
  • The Revenue is expected to grow by 2.64% on average over the next years.
EPS Next Y18.51%
EPS Next 2Y-13.49%
EPS Next 3Y10.11%
EPS Next 5Y6.65%
Revenue Next Year1.23%
Revenue Next 2Y2.83%
Revenue Next 3Y3.72%
Revenue Next 5Y2.64%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
6MK.DE Yearly Revenue VS Estimates6MK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
6MK.DE Yearly EPS VS Estimates6MK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • 6MK is valuated correctly with a Price/Earnings ratio of 13.85.
  • 6MK's Price/Earnings ratio is a bit cheaper when compared to the industry. 6MK is cheaper than 72.73% of the companies in the same industry.
  • 6MK is valuated rather cheaply when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 21.33, which indicates a rather expensive current valuation of 6MK.
  • 6MK's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 27.20. 6MK is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.85
Fwd PE 21.33
6MK.DE Price Earnings VS Forward Price Earnings6MK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 6MK is valued a bit cheaper than the industry average as 67.27% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, 6MK is valued a bit cheaper than the industry average as 61.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 23.2
EV/EBITDA 11.04
6MK.DE Per share data6MK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 6MK has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.75
PEG (5Y)1.72
EPS Next 2Y-13.49%
EPS Next 3Y10.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.14%, 6MK has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.95, 6MK pays a bit more dividend than its industry peers.
  • 6MK's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.14%

5.2 History

  • On average, the dividend of 6MK grows each year by 6.90%, which is quite nice.
Dividend Growth(5Y)6.9%
Div Incr Years8
Div Non Decr Years8
6MK.DE Yearly Dividends per share6MK.DE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 42.60% of the earnings are spent on dividend by 6MK. This is a bit on the high side, but may be sustainable.
  • The dividend of 6MK is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP42.6%
EPS Next 2Y-13.49%
EPS Next 3Y10.11%
6MK.DE Yearly Income VS Free CF VS Dividend6MK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
6MK.DE Dividend Payout.6MK.DE Dividend Payout, showing the Payout Ratio.6MK.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

MERCK & CO. INC.

FRA:6MK (2/5/2026, 7:00:00 PM)

103.2

+1.8 (+1.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30
Earnings (Next)02-03
Inst Owners80.32%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap256.14B
Revenue(TTM)64.23B
Net Income(TTM)19.03B
Analysts77.06
Price Target97.86 (-5.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.14%
Yearly Dividend2.6
Dividend Growth(5Y)6.9%
DP42.6%
Div Incr Years8
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.37%
Min EPS beat(2)7.69%
Max EPS beat(2)13.06%
EPS beat(4)4
Avg EPS beat(4)7.28%
Min EPS beat(4)2.93%
Max EPS beat(4)13.06%
EPS beat(8)8
Avg EPS beat(8)21.72%
EPS beat(12)12
Avg EPS beat(12)16.45%
EPS beat(16)16
Avg EPS beat(16)15.36%
Revenue beat(2)1
Avg Revenue beat(2)-0.35%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)0.83%
Revenue beat(4)2
Avg Revenue beat(4)-0.09%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)0.83%
Revenue beat(8)5
Avg Revenue beat(8)0.41%
Revenue beat(12)9
Avg Revenue beat(12)1.14%
Revenue beat(16)13
Avg Revenue beat(16)1.98%
PT rev (1m)3.86%
PT rev (3m)12.56%
EPS NQ rev (1m)-2.26%
EPS NQ rev (3m)-8.36%
EPS NY rev (1m)-0.09%
EPS NY rev (3m)0.64%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE 13.85
Fwd PE 21.33
P/S 4.71
P/FCF 23.2
P/OCF 17.74
P/B 5.84
P/tB 20.25
EV/EBITDA 11.04
EPS(TTM)7.45
EY7.22%
EPS(NY)4.84
Fwd EY4.69%
FCF(TTM)4.45
FCFY4.31%
OCF(TTM)5.82
OCFY5.64%
SpS21.9
BVpS17.67
TBVpS5.1
PEG (NY)0.75
PEG (5Y)1.72
Graham Number54.43
Profitability
Industry RankSector Rank
ROA 14.69%
ROE 36.71%
ROCE 24.24%
ROIC 12.83%
ROICexc 15.66%
ROICexgc 28.27%
OM 38.08%
PM (TTM) 29.63%
GM 78.72%
FCFM 20.31%
ROA(3y)9.42%
ROA(5y)9.66%
ROE(3y)23.17%
ROE(5y)26.32%
ROIC(3y)13.67%
ROIC(5y)12.02%
ROICexc(3y)15.77%
ROICexc(5y)13.76%
ROICexgc(3y)34.22%
ROICexgc(5y)31.54%
ROCE(3y)25.81%
ROCE(5y)22.7%
ROICexgc growth 3Y7.57%
ROICexgc growth 5Y3.37%
ROICexc growth 3Y15.27%
ROICexc growth 5Y10.69%
OM growth 3Y5.75%
OM growth 5Y7.99%
PM growth 3Y-0.15%
PM growth 5Y1.18%
GM growth 3Y1.92%
GM growth 5Y1.45%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 3.17
Debt/EBITDA 1.38
Cap/Depr 87.9%
Cap/Sales 6.25%
Interest Coverage 18.43
Cash Conversion 58.79%
Profit Quality 68.56%
Current Ratio 1.66
Quick Ratio 1.44
Altman-Z 4.37
F-Score6
WACC8.93%
ROIC/WACC1.44
Cap/Depr(3y)95.66%
Cap/Depr(5y)110.48%
Cap/Sales(3y)6.36%
Cap/Sales(5y)7.78%
Profit Quality(3y)903.98%
Profit Quality(5y)573.68%
High Growth Momentum
Growth
EPS 1Y (TTM)48.07%
EPS 3Y6.87%
EPS 5Y8.04%
EPS Q2Q%70.7%
EPS Next Y18.51%
EPS Next 2Y-13.49%
EPS Next 3Y10.11%
EPS Next 5Y6.65%
Revenue 1Y (TTM)1.68%
Revenue growth 3Y9.63%
Revenue growth 5Y10.4%
Sales Q2Q%3.72%
Revenue Next Year1.23%
Revenue Next 2Y2.83%
Revenue Next 3Y3.72%
Revenue Next 5Y2.64%
EBIT growth 1Y2.78%
EBIT growth 3Y15.93%
EBIT growth 5Y19.23%
EBIT Next Year27.75%
EBIT Next 3Y13.67%
EBIT Next 5Y11.96%
FCF growth 1Y-0.9%
FCF growth 3Y23.27%
FCF growth 5Y12.67%
OCF growth 1Y-0.73%
OCF growth 3Y15.02%
OCF growth 5Y9.82%

MERCK & CO. INC. / 6MK.DE FAQ

Can you provide the ChartMill fundamental rating for MERCK & CO. INC.?

ChartMill assigns a fundamental rating of 6 / 10 to 6MK.DE.


What is the valuation status for 6MK stock?

ChartMill assigns a valuation rating of 5 / 10 to MERCK & CO. INC. (6MK.DE). This can be considered as Fairly Valued.


What is the profitability of 6MK stock?

MERCK & CO. INC. (6MK.DE) has a profitability rating of 7 / 10.


What are the PE and PB ratios of MERCK & CO. INC. (6MK.DE) stock?

The Price/Earnings (PE) ratio for MERCK & CO. INC. (6MK.DE) is 13.85 and the Price/Book (PB) ratio is 5.84.


Is the dividend of MERCK & CO. INC. sustainable?

The dividend rating of MERCK & CO. INC. (6MK.DE) is 6 / 10 and the dividend payout ratio is 42.6%.